Navigation Links
Genzyme Reports Strong First-Quarter Growth
Date:4/23/2008

of this product franchise.

-- Sales of Sepra(R) products continued to be strong, rising 32 percent to

$30.6 million in the first quarter from $23.1 million in the same

quarter a year ago. The expanded U.S. sales force for Seprafilm(R)

adhesion barrier is reaching a broader range of physicians and helping

drive the product's growth in gynecologic and colorectal surgery.

Future growth of the product in C-section procedures and trauma

surgeries is expected.

-- First-quarter revenue for the Genetics business increased 12 percent to

$74.3 million from $66.2 million, fueled substantially by a higher

volume of reproductive diagnostic testing. The profitability of the

Genetics business is also increasing through improvements in operating

efficiencies, while Genzyme continues to invest in additional

information technology and infrastructure to strengthen the competitive

advantages the business has created. Genzyme Genetics recently

launched carrier and prenatal diagnostic testing for spinal muscular

atrophy, the most common inherited cause of infant mortality. These

tests are expected to support continued profitable growth in subsequent

quarters.

-- Oncology revenue increased 29 percent in the first quarter to $29.0

million from $22.4 million. This growth primarily reflects the

addition of European sales of Clolar, which Genzyme began recording

following its acquisition of Bioenvision Inc. late last year. Genzyme

is working to introduce Clolar worldwide through its global commercial

and regulatory organization. Oncology revenue also reflects growing

first-line use of Campath(R) (alemtuzumab) in the treatment of patients

with B-cell chronic lymphocytic leukemia.

Late-State Development Programs

Genzyme continues to make strong prog
'/>"/>

SOURCE Genzyme Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Genzyme to Build New R&D Center in Beijing
2. Genzyme Provides Update on Myozyme(R) Manufacturing
3. Genzyme Withdraws Bioenvisions European Filing of Evoltra(R) in Elderly AML Patients
4. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
5. Genzyme and Isis Announce Hart-Scott-Rodino Approval of Collaboration
6. Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
7. BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture
8. Genzyme Receives European CE Mark for Single-Treatment Synvisc-One(TM)
9. Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation
10. Genzyme Study of Myozyme(R) for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
11. Genzyme and Sunway to Collaborate on Gene Therapy Program in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... SAN FRANCISCO , March 31, 2015  Sonoa ... Melbourne, Australia , has developed a world-first consumer ... health records, medication prescriptions, wearable devices and more. ... John Stewart as its CEO, who brings to ... and corporate advisory, which has included working closely with ...
(Date:3/31/2015)... 2015   Mapi expands Pharmacovigilance and ... and global Risk Management strength with the expanded ... acquisition . Pharmacovigilance and ... global team that includes physicians, pharmacists, and numerous ... in navigating complex safety requirements throughout the product ...
(Date:3/31/2015)... NEW YORK , March 31, 2015 /PRNewswire/ ... biopharmaceutical company advancing protein biologic therapies and oncology ... marketing partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: ... the country,s Ministry of Food and Drug Safety ... (KTR) for MuGard, its oncology supportive-care treatment for ...
(Date:3/31/2015)... 2015 This June 13th, a distinguished ... U.S and International Medical Schools will come together in ... the application of stem cell therapy in treatments and ... and funded by the Ocular Research Symposia Foundation, ... convening intimate meetings of top experts in the field ...
Breaking Biology Technology:Investment Banker Appointed CEO of Australian Health Tech Start-Up 2Investment Banker Appointed CEO of Australian Health Tech Start-Up 3Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2
... of the first-ever prototype positron emission tomography (PET) ... the scanner could advance the quality and spatial ... SNM,s 55th Annual Meeting. The prototype scanner already ... and nasopharyngeal cancer. Eventually, the technology could be ...
... his team have developed a model to explain the ... switch. , If born out experimentally, his work could ... , Moore,s Law predicts that the number of transistors ... will double about every two years. But by 2020, ...
... VIEJO, Calif., June 16 The Ensign,Group, Inc. (Nasdaq: ... group of,skilled nursing, rehabilitative care services and assisted living,companies, ... a,quarterly cash dividend of $0.04 per share of Ensign ... shareholders of record as of June 30, 2008.,Ensign has ...
Cached Biology Technology:First semiconductor-based PET scanner demonstrates potential to aid in early diagnosis of disease 2Michigan Tech scientist models molecular switch 2The Ensign Group Declares Quarterly Dividend 2
(Date:3/20/2015)... DUBLIN , Mar. 20, 2015 Research ... announced the addition of the "India Sensors ... their offering. The sensor market is ... through 2020 Consumer electronics, automotive, industrial ... for sensors in the country. In addition, adoption ...
(Date:3/19/2015)... OXFORD, Conn. , March 19, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce market, ... featured in a news clip that aired this week on ... http://www.myfoxdc.com/ ) . In a segment "The Next ... smart wallet ,a new way to pay, and ,a really ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
Breaking Biology News(10 mins):India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... in mind what has just been seen by synchronizing brain ... by the National Institutes of Health suggests. The more in-sync ... of the circuit, the more those cells held the short-term ... Montana State University, Bozeman, a grantee of NIH,s National Institute ...
... Researchers at the University of Bergen in Norway have ... causes a temporary cognitive breakdown in non-psychotic individuals, leading ... week in Frontiers in Psychiatry , researchers found ... previous cannabis use than in schizophrenic patients without prior ...
... MERCED, Calif. California isn,t going to face a superstorm ... to feed that kind of weather system. But that ... the University of California, Merced. "We can see very ... to climate change to think about," said Roger Bales, director ...
Cached Biology News:In-sync brain waves hold memory of objects just seen 2Cannabis use mimics cognitive weakness that can lead to schizophrenia 2California is home to extreme weather, too 2California is home to extreme weather, too 3
HIF-1 beta (ARNT1) Purified Anti-Mouse, Anti-Rat, Anti-Human clone 29, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
Anti-TWIK-1 Immunogen: Purified peptide from amino acids 53-69 of human TWIK-1 (Accession number O00180)....
This antibody detects an ~92 kDa protein corresponding to the apparent molecular mass of the beta subunit of Hypoxia Inducible Factor-1 (HIF-1beta) on Western blots....
Complexin-1/2 (FL-134)...
Biology Products: